Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2000

View Archived Issues

New study assesses Accupril post-CABG

MitoKor acquires Chiron's Australian subsidiary

AMBI to receive patent for use of calcium taurate with antihypertensive agents

KS Biomedix plans to move two products into phase III trials

Pharmacia & Upjohn submits applications for once-daily Detrol formulation

MDM2 antisense inhibitor collaboration ended by Hybridon and Searle

Millennium gains broad access to XenoMouse technology

Nycomed Amersham highlights product development efforts for year-end 1999

Corixa, QLT team up to expand the possibilities of photodynamic therapy

FDA grants fast track status to BNP-7787 for treating paclitaxel-induced neurotoxicity

NIH grant to support Alexion's 5G1.1 in lupus trials

New formulation of Agouron's Viracept approved in U.S.

Neurocrine initiates first in a series of clinical trials for insomnia treatment

New nondrug treatment approved for rheumatoid arthritis in Canada

The FDA approves Viadur for once-yearly palliative treatment of advanced prostate cancer

GelTex provides clinical update for Q4 and year-end 1999

Dexanabinol effective in preclinical MS model

Immune Response assesses brain tumor vaccine in phase I trial

Xoma steps up antibody development, licenses BPI platform during 1999

Novel antitumor antibiotic identified from Streptomyces strain

Taisho presents new series of cytokine production inhibitors

Nociceptin receptor ligands from Schering-Plough with potential as antitussives, analgesics, etc.

Further developments at Lilly in the area of glutamate receptor potentiation

Vasogen receives go-ahead from FDA to commence clinical trial of CHF treatment

Warner-Lambert synthesizes and evaluates new dopamine agonists

Antitussive activity of SB-227122, a potent and selective delta-opioid receptor agonist

Novel dinoflagellate-produced macrolide is cytotoxic to leukemia cells

Antibiotic complex discovered by German researchers possesses antimicrobial and antitumor effects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...